Skip to content
Review

Sleep-wake control with age and neurodegenerative diseases.

Aug 2026 · Sleep Medicine Reviews · Vol 90, pp. 102352 · 1 citation · 159 references
Medicine

TL;DR

Evidence linking sleep disorders with neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, progressive supranuclear palsy, Huntington's disease, Huntington's disease, and amyotrophic lateral sclerosis is discussed.

Abstract

Aging causes dramatic alterations in bodily functions. Among them, sleep quality declines with age, particularly in individuals with neurodegenerative diseases. In this review, we first describe alterations in sleep-wake architecture and discuss potential mechanisms underlying sleep disorders that arise with age. We discuss evidence linking sleep disorders with neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), progressive supranuclear palsy (PSP), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) syndrome. Even though the causes of AD, PD, PSP, and HD are diverse, several shared symptoms including difficulty falling asleep, fragmented sleep, and disrupted circadian rhythm collectively suggest their pathologies disrupt sleep-wake control. Hyperexcitability of implicated neurons is commonly observed prior to neurodegeneration. Upregulated neuronal excitability in the early phase of these diseases appears as a potential shared mechanism among neurodegenerative diseases. Abnormal protein accumulation and aggregation in these diseases exacerbate neuronal circuit hyperactivity by increasing neurons' intrinsic excitability or dampening inhibitory inputs to neurons controlling sleep-wake cycles. A better understanding of the mechanisms underlying sleep disorders that emerge with age may greatly benefit the development of novel preventative and therapeutic strategies for neurodegenerative diseases, and therefore improve the life quality of older adults.

View source

Similar papers

Review Open access Oct 2026

Sleep Loss and Alzheimer’s Disease: Mechanisms, Risk Factors, and Cognitive Consequences—A Narrative Review

Sleep loss is increasingly recognized as a potentially modifiable factor in cognitive aging and Alzheimer’s disease (AD). Evidence supports a bidirectional relationship in which sleep disruption may both reflect early AD-related neurodegenerative changes and contribute to disease progression. This narrative review them...

Antoniya Hachmeriyan, G. Panayotova, Annriya Anand et al. · 0 citations
Review 2026

REM sleep behavior disorder and synucleinopathies.

This chapter discusses how RBD provides a window for testing neuroprotective and disease-modifying therapies that may delay or prevent overt synucleinopathy and reviews current symptom management approaches that mix pharmacological treatment with non-pharmacological safety measures for injury prevention and neuromodula...

N. Uzma, Maryam Wajdi, Aasea Alhashmi et al. · 0 citations
Review Open access Sep 2026

Mechanisms of Brain Aging and Their Links to Alzheimer’s and Parkinson’s Disease Pathology

Brain aging is a major risk factor for neurodegenerative disorders and is associated with a progressive loss of neuronal homeostasis. Rather than resulting from a single pathological event, brain aging involves coordinated changes across multiple biological processes, including neuroinflammation, proteostasis impairmen...

Hai-Yi Yi, Hai-Meng Qin, J. Goon et al. · 0 citations
Review Open access Sep 2026

Sleep and stress as modifiable drivers of Alzheimer’s disease

The intricate links between sleep, stress, and Alzheimer’s disease, including underlying neural circuitry and mechanisms that contribute to disease are highlighted, including specific brain region involvements, the contribution of molecular mechanisms of disease, and translational opportunities which may arise.

Darcy Wear, S. A. Hussaini, Wai Haung Yu · 0 citations
Review Oct 2026

What can narcolepsy teach us about hypocretin and dementia?

Sleep and circadian disturbances are associated with cognitive decline and dementia. Narcolepsy type 1 (NT1), characterized by severe sleep-wake disruption and loss of hypocretin, would therefore be expected to predispose individuals to premature brain aging. Yet available biomarker and neuroimaging findings do not con...

Renata K. Carvalho, T. Alvarenga, F. Coelho et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.